Exchange: NASDAQ·Updated 07:30 PM EDT
CRVS logo

CRVS Corvus Pharmaceuticals Inc

$10.68
$0.12
(1.13%)
Today
Closed $10.53
$0.15
(1.43%)
After Hours
EarningsNov 3
Mkt Cap$885.79M
Vol933,772.00

About CRVS

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.
45

Neutral Sentiment

How do you feel about CRVS?

ILikeDaStocks
$CRVS Dear God, please allow one of my other holdings to pop so I can own more CRVS at these ridiculously low prices. Amen. 🙏🛐😂
1
5
Gaia2
$CRVS There is a lot of big money in crvs. Sooner or later the big money will get together and squeeze the shorts. Its just too tempting and the rewards will be too great! A squeeze is coming.
7
JFais
$CRVS (NP) At $750M EV, the indications are starting to stack up for soquelitinib PTCL in phase 3, both AD & ALPS in phase 2 Phase 1b in HS now underway, asthma to follow Showcases ITK's broad potential due to Th2/Th17 blockade CoM through 2042 = plenty of time to prosecute
7
abc12332
$CRVS Let’s talk ALPS, my favorite CRVS topic. It’s honestly been confusing. I am now pretty confident in the data being good. I was dis with delays and avoidance which of course markets and investors hate bu reviewing what we know: -The biology is rock solid. Most ALPS patients have a FAS gene mutation inhibiting apoptosis of Tcells causing the disease. The MOA of Soquel suggests strongly that it can correct the pathway allowing normal apoptosis. In FAS deficient mice it works like a charm -CRVS Previously updated ALPS at CC’s and had it on their catalyst and milestone slide. In fact first update was listed as mid 2026. -In January 2026 Miller did a Biotect TV talking about Soquel mostly in AD. Cont. interview the
7
renata1
$CRVS The drug is also being developed for atopic dermatitis and hidradenitis suppurativa. Success in inflammatory diseases could give CRVS opportunities beyond cancer!!
5
TheGunnerAB
$CRVS 1,000 of January 2028 $20/$40 call spreads were bought for a debit if $1.48 or $148K. Lots of action lately
1
3
Trading_Edge
$CRVS — Corvus just started a Phase 1b trial of soquelitinib in hidradenitis suppurativa, taking its selective ITK inhibitor into another inflammatory disease opportunity. This is particularly interesting because soquelitinib isn’t being developed around just one indication. More clinical shots on goal means more upcoming data that can help determine whether the mechanism has broader potential.
6
tradingjunk321
$CRVS at 4am 3,750 shares traded at $10.55 🤔. Make you wonder if something big is about to happen w/all those recent option trades!
5
Gaia2
$CRVS Don't overlook the work CRVS is doing with TREG cells. This could be the most lucrative thing in their pipeline. They're just beginning to scratch the surface.
5
tradingjunk321
$CRVS same feeling and this is what I've been saying a for a while, but I believe Miller is a little older!
5
TheGunnerAB
$CRVS Very strange, someone bought almost 1,300 of $CRVS January 2028 $40 call for $1.5-$1.8. Why buy so for out of the money and SP? Need to check the OI on Monday to ensure it was to open.
5
tradingjunk321
$CRVS I don't know if I'd like a $35 over night cash buyout to F the shorts or $50-100 long term 🤔. $35+ I'll be good! The Moore the merrier!
5
Mr_Predicto
$CRVS FYI, the worst is not over. I'm not saying it will go down in a straight line, but cheap will become cheaper, and "discounts" will be further discounted. The primary reason is because there is practically no incentive to buy the stock at this time or at these levels. Even if you believe the science will bear fruit (eventually), there are no catalysts expected for months. Those results may get delayed again (as we have heard on recent company calls and "chats"). Aside from the disappointment of delays themselves, it makes me wonder if there is a specific underlying cause for them that the company has yet to share. Prediction: Will be knocking on the door to single digits before long.
1
2
KingKai2020
$CRVS $11.60 avg for 50k shares total. Biggest trade/short term bet in a while! I think the freak out over 10yr yields is wring at Q3 gpd is now estimated at 5.1% with cpi at 2.4% for 7.5% nominal gdp. strong economy with people worried abt 0.4% over teh Fed 2.0% inflation target with Iran/Russia/Ukraine all happening at once...said another way, inflation is tame and any easing of energy will spike equities given a stron 2027 s&p earnings estimate that continues to rise.
5
ILikeDaStocks
$CRVS God I love it when my favorite company declines more and more and I can accumulate cheaper and cheaper! I have zero doubt (none!) that Soquelitinib's future real-life medical applications will boggle the mind!!
4
GaryGherkins
$CRVS where the hll is in honor of thomas w. phelps at moments like this. i followed his advice & now im back sleeping on the park bench
4
Jellysquid1
$CRVS Bought More Now! Getting a cheaper price Than what INSIDERS Bought at …And they Know Crvs will go higher!
4
TheGunnerAB
$CRVS Someone bought 1000 of $CRVS $12 calls that expire tomorrow for 5c and another one sold 10,000 of the January $9 puts for $1.2. That's $1.2M in credit premium.
3
Mr_Predicto
$CRVS I can appreciate the temptation to buy based on an announced study. The more irons you have in the fire, the better. The more lottery tickets you buy the better your chances right? Sure, but do your chances increase with any significance? You are betting on hope. Hope is worth the 5 bucks spent on lottery tickets. Is it worth thousands in potential loss? Prediction: Spin the wheel.
3
Jellysquid1
$CRVS Top Trending Money Making Stocks Today Are All BIOTECHS! Best Place to make $$$ CRVS …a Good Investment! Buy CRVS and……
3

Advertisement|Remove ads.